4//SEC Filing
McBarron Paul 4
Accession 0001104659-23-077657
CIK 0001130166other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 4:57 PM ET
Size
5.8 KB
Accession
0001104659-23-077657
Insider Transaction Report
Form 4
McBarron Paul
DirectorEVP, Finance, CFO, COO
Transactions
- Award
Stock Option (right to buy)
2023-06-30+70,200→ 70,200 totalExercise: $0.59From: 2024-06-30Exp: 2033-06-30→ Common Stock (70,200 underlying)
Footnotes (1)
- [F1]The reporting person received an award of 70,200 options on June 30, 2023, which shall vest in full on June 30, 2026, provided, however, that if certain clinical milestones are achieved then such options shall vest in full earlier in connection with such achievement.
Documents
Issuer
Cyclacel Pharmaceuticals, Inc.
CIK 0001130166
Entity typeother
Related Parties
1- filerCIK 0001357397
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 4:57 PM ET
- Size
- 5.8 KB